Gokshuradi Guggulu With Musta Panaka as Anupana and Lodhra Vata Twaka Kashaya Yoni Prakshalana in Abnormal vaginal Discharge
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: N771- Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere
- Registration Number
- CTRI/2024/07/071280
- Lead Sponsor
- Government Ayurveda College and Hospital Tripunithura
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients complaining of abnormal vaginal discharge as cardinal symptom.
Exclusion Criteria
1. Post-menopausal women
2. Pregnant and lactating women
3. Any type of malignancy
4. Patient having STDs.
5. Patient with uncontrolled diabetes mellitus
6. Known case of any organic pathology of reproductive organs with cervical polyp and cervical or vaginal cancer.
7. Any discharge contaminated with urine or faecal matter
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To check the amount of Abnormal Vaginal Discharge on basis of the Likert scale and Scoring PatternTimepoint: 0th day, 31st day, 61st day
- Secondary Outcome Measures
Name Time Method To Evaluate the Change in Vaginal swab culture & Vaginal pHTimepoint: 0th day, 31st day, 61st day;To evaluate the effect of oral administration of gokshuradi guggulu with musta panaka as anupana lodhra vata twak kashaya yoni prakshalana in colour, consistency, smell, itching and burning sensation of abnormal vaginal dischargeTimepoint: Patients will be assessed on basis of scoring pattern on 0th day, 31st day and 61st day
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Gokshuradi Guggulu's efficacy in treating N771 vaginitis?
How does Gokshuradi Guggulu with Musta Panaka compare to standard-of-care treatments for abnormal vaginal discharge?
Are there specific biomarkers that predict response to Lodhra Vata Twaka Kashaya Yoni Prakshalana in vulvovaginitis?
What are the potential adverse events associated with Gokshuradi Guggulu and Lodhra-based interventions in phase II trials?
What combination therapies or Ayurvedic alternatives are being explored alongside Gokshuradi Guggulu for N771-related gynecological conditions?